The Pre-College Visit: Vaccines, Confidentiality, and Screening
Nadia is 17 years and 9 months old and comes alone for a pre-college physical. She has no chronic conditions and takes no medications. Immunization record: DTaP series complete; Tdap at age 11; MenACWY at age 11; HPV doses at 11 and 12 (series complete); influenza never; no MenB; COVID-19 primary series only, no recent booster. She reports one lifetime sexual partner, condom use 'most of the time,' and no history of STI testing. She works part-time and will live in a dorm. She asks that her parents not be told about anything discussed. PHQ-2 is negative; she denies tobacco, alcohol, and cannabis use; AUDIT-C 0.
1. Which vaccines should be offered at this visit, and what is the rationale for each?
Read the worked answer
Nadia needs a MenACWY booster now. She received her primary dose at age 11, and a booster at age 16 or older is recommended for adolescents who had their first dose before age 16; many colleges also require this. She has no MenB series, so offer MenB vaccination using shared clinical decision-making for ages 16-23, explaining that it protects against serogroup B disease and is given as a 2-dose series 6 months apart. Influenza vaccine should be given annually and is due now.
Her HPV series is complete, so no additional HPV doses are needed. Her Tdap at age 11 covers tetanus and diphtheria for 10 years, so a Td booster is not due until about age 21 unless she has a wound requiring it. COVID-19 vaccination should follow current national guidance, including any recommended booster for her age and risk group. Check that hepatitis B, MMR, and varicella are complete, since college entry often prompts catch-up. Document doses in the state registry and give her a copy of the record.
2. How do you respond to her request that her parents not be told anything, and what are the limits of confidentiality?
Read the worked answer
Start by explaining confidentiality and its limits before taking sensitive history: what she says stays private unless there is imminent risk of harm to herself or others, suspected abuse or neglect, or a reportable condition. She should also understand that electronic insurance explanations of benefits can disclose visits to a policyholder even when the clinician does not tell a parent. That is a systems issue, not a promise the clinician can personally guarantee.
At 17, she can likely consent to STI testing and some reproductive care under state minor-consent laws, but contraception and other services vary by state. Use a confidential billing option when available, such as a Title X clinic, self-pay, or a separate policy. Offer time alone at every visit and document her preferences. If a safety issue arises, tell her in advance what must be shared and involve her in how the disclosure happens rather than promising absolute secrecy.
3. What screening and counseling should be completed at this visit?
Read the worked answer
Screen for STI risk with a urine or self-collected vaginal swab nucleic acid amplification test for chlamydia and gonorrhea, plus HIV and syphilis testing based on risk and local prevalence; pregnancy testing if there is any concern. Discuss contraception and emergency contraception, condom use, and reproductive coercion. Cervical cancer screening is not indicated before age 21, and a routine pelvic examination is not needed. Check blood pressure and BMI. Depression screening is negative on PHQ-2, but ask about sleep, stress, and functioning during the transition to college.
Counsel on seatbelt use, helmet use, safe driving, sleep, nutrition, and avoiding alcohol and cannabis. Discuss meningococcal disease symptoms and the importance of the MenB series. Address the transition of care: how she will refill prescriptions, find a clinician at college, and access confidential services. Give written vaccine records and a clear plan for the second MenB dose. Reinforce that she can return with any concern and that confidential care remains available.